Nutex Health Inc.
NUTX
$178.00
$9.585.69%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 9.76% | 15.20% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 9.76% | 15.20% | |||
| Cost of Revenue | -5.18% | 28.81% | |||
| Gross Profit | 22.83% | 5.46% | |||
| SG&A Expenses | -73.13% | 142.18% | |||
| Depreciation & Amortization | -4.67% | 3.06% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -34.65% | 60.38% | |||
| Operating Income | 287.09% | -58.25% | |||
| Income Before Tax | 422.24% | -66.68% | |||
| Income Tax Expenses | 257.67% | -62.82% | |||
| Earnings from Continuing Operations | 499.60% | -68.22% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -22.23% | -14.37% | |||
| Net Income | 413.25% | -183.41% | |||
| EBIT | 287.09% | -58.25% | |||
| EBITDA | 247.75% | -54.61% | |||
| EPS Basic | 380.23% | -178.87% | |||
| Normalized Basic EPS | 269.88% | -220.47% | |||
| EPS Diluted | 362.87% | -193.39% | |||
| Normalized Diluted EPS | 258.61% | -242.37% | |||
| Average Basic Shares Outstanding | 11.78% | 5.75% | |||
| Average Diluted Shares Outstanding | 19.73% | -10.52% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||